SCHEMBL6492253

SCHEMBL6492253

Cc1cncc(C(=O)Nc2cccc(C(=O)c3ccc4cnn(/C=C/c5ccccc5)c4c3)c2)c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 7/20 0.60
CSF1R P07333 2/20 0.41
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
KCNK3 O14649 2/20 0.40
POLB P06746 1/20 0.40
KCNK9 Q9NPC2 1/20 0.40
ACKR3 P25106 2/20 0.40
SMN1; SMN2 Q16637 1/20 0.39
GALR2 O43603 1/20 0.39
LMNA P02545 1/20 0.39
MAPT P10636 1/20 0.39
HPGD P15428 1/20 0.39
RECQL P46063 1/20 0.39
SNCA P37840 2/20 0.39
FGFR1 P11362 1/20 0.39
MET P08581 1/20 0.39
PTGS2 P35354 1/20 0.39
AGTR1 P30556 1/20 0.39
RAB9A P51151 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5254004 1.00 KDR (0.60) KDRCSF1RMEN1KMT2AKCNK3
SCHEMBL5249872 0.87 KDR (0.56) KDRKMT2AKCNK3POLBKCNK9
SCHEMBL5246823 0.83 KDR (0.44) KDRMEN1KMT2ALMNAMAPT
SCHEMBL5255512 0.83 KCNK3 (0.51) KDRMEN1KMT2AKCNK3KCNK9
SCHEMBL5247789 0.83 KDR (0.55) KDRMEN1KMT2ASMN1; SMN2LMNA
SCHEMBL5247750 0.82 KDR (0.59) KDRKCNK3POLBKCNK9SNCA
SCHEMBL5251706 0.82 KDR (0.45) KDRMEN1KMT2AKCNK3POLB
SCHEMBL5248278 0.80 KDR (0.59) KDRMEN1KMT2AKCNK3KCNK9
SCHEMBL5249333 0.79 KDR (0.58) KDRMEN1KMT2APOLBSMN1; SMN2
SCHEMBL5250961 0.79 KMT2A (0.43) KDRMEN1KMT2AKCNK3POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6884890-B2 Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use AGOURON PHARMACEUTICALS, INC. (US) 2005-04-26 US disclosed